We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Purpose-Oriented Robot Augments Laparoscopic Surgery

By HospiMedica International staff writers
Posted on 13 Jan 2021
Print article
Image: The Dexter Surgical Robot assists laparoscopic procedures (Photo courtesy of Distalmotion)
Image: The Dexter Surgical Robot assists laparoscopic procedures (Photo courtesy of Distalmotion)
An affordable surgical robot brings simplicity and versatility to a range of minimally invasive laparoscopic procedures.

The Distalmotion (Lausanne, Switzerland) Dexter Surgical Robot is designed to reduce the complexity of robotic surgery by integrating seamlessly with all existing laparoscopic setups and workflows. Dexter is based on two fully articulated robotic arms that use single-use instruments for suturing and dissection, including a standard line-up of 8 mm vessel sealers, staplers, and monopolar and bipolar electrosurgical instruments. The robotic arms can be individually realigned to change trocar sites, and are designed to provide working space for the assistant surgeon to hold the endoscope and retraction equipment.

The mobile, adaptable, open console supports optimal ergonomic postures, providing surgeons with the choice to operate the robot in a seated or standing position. The console is draped and placed close to the patient (within the surgical field), allowing the operating team to switch between laparoscopic and robotic surgery. The modular platform can be used with any commercial laparoscopic tower, including 4k, 3D, ICG or any other current or future imaging technology. To facilitate adoption, Dexter is built on a transparent pay-per-use model that foregoes large lump-sum investment costs.

“Dexter has already garnered tremendous interest in the surgical community and we look forward to answering the increasing demand for a medical device removing the complexity out of robotic surgery to fast track its widespread adoption in minimally invasive surgical care,” said Michael Friedrich, CEO of Distalmotion. “Following the validation of our product clinical value and benefits earlier this year, I am now looking forward to starting a broader movement allowing every patient to access the benefits of robotic surgery.”

Related Links:
Distalmotion

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Vital Signs Monitor
Aurus 10

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.